Protokinetix Financial Statements From 2010 to 2024

PKTX Stock  USD 0.01  0.0003  3.30%   
Protokinetix financial statements provide useful quarterly and yearly information to potential Protokinetix investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Protokinetix financial statements helps investors assess Protokinetix's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Protokinetix's valuation are summarized below:
Protokinetix does not presently have any trending fundamental ratios for analysis.
Check Protokinetix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protokinetix's main balance sheet or income statement drivers, such as , as well as many indicators such as . Protokinetix financial statements analysis is a perfect complement when working with Protokinetix Valuation or Volatility modules.
  
This module can also supplement various Protokinetix Technical models . Check out the analysis of Protokinetix Correlation against competitors.

Protokinetix Company Return On Equity Analysis

Protokinetix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Protokinetix Return On Equity

    
  -4.03  
Most of Protokinetix's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Protokinetix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Protokinetix has a Return On Equity of -4.0255. This is 83.21% lower than that of the Healthcare sector and 88.96% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.

Protokinetix Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Protokinetix's current stock value. Our valuation model uses many indicators to compare Protokinetix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Protokinetix competition to find correlations between indicators driving Protokinetix's intrinsic value. More Info.
Protokinetix is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Protokinetix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Protokinetix's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Protokinetix Financial Statements

Protokinetix investors use historical fundamental indicators, such as Protokinetix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Protokinetix. Please read more on our technical analysis and fundamental analysis pages.
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins or anti-aging glycoproteins . ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio. Protokinetix is traded on OTC Exchange in the United States.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protokinetix Pink Sheet Analysis

When running Protokinetix's price analysis, check to measure Protokinetix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protokinetix is operating at the current time. Most of Protokinetix's value examination focuses on studying past and present price action to predict the probability of Protokinetix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protokinetix's price. Additionally, you may evaluate how the addition of Protokinetix to your portfolios can decrease your overall portfolio volatility.